reference/6836152

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6836152

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	444
issn	1365-2036 0269-2813
issueIdentifier	3
pageRange	437-444
publicationName	Alimentary Pharmacology & Therapeutics
startingPage	437
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0f7aba84a3749554185f5b5860982b79 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9eaf7593358c8b00df2d8dfc699ba84a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15b60280d0432b150fc577332a684b67 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d60cd16b3b3ae4933f1a96073982fc2
bibliographicCitation	METZ DC, COMER GM, SOFFER E, FORSMARK CE, CRYER B, CHEY W, PISEGNA JR. Three‐year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions. Aliment Pharmacol Ther. 2006 Jan 16;23(3):437–44. doi: 10.1111/j.1365-2036.2006.02762.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fa27b75ff3f377667931c42e82579e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01fb441bfa6e5f89486b2055cd6d515f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b44883df1fdf900618d5921492384e04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68ead21c4019eee447f2414473e5ed24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ed6b176baa7d73e5fdc3166f1f40005 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72df631dff82b7d285088f4c438d86bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_586016837529dd92d016207024bcd75a
date	2006-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16423003 https://doi.org/10.1111/j.1365-2036.2006.02762.x https://pubmed.ncbi.nlm.nih.gov/PMC6736592
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1160 https://portal.issn.org/resource/ISSN/0269-2813 https://portal.issn.org/resource/ISSN/1365-2036
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Three‐year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions
discusses	http://id.nlm.nih.gov/mesh/M0001340 http://id.nlm.nih.gov/mesh/M0177102 http://id.nlm.nih.gov/mesh/M0015293 http://id.nlm.nih.gov/mesh/M0496552 http://id.nlm.nih.gov/mesh/M0020796 http://id.nlm.nih.gov/mesh/M0002348
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001562Q000627 http://id.nlm.nih.gov/mesh/D000897Q000627 http://id.nlm.nih.gov/mesh/D015043Q000188 http://id.nlm.nih.gov/mesh/D013454Q000627 http://id.nlm.nih.gov/mesh/D009853Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005744Q000378 http://id.nlm.nih.gov/mesh/D009853Q000627 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D053799 http://id.nlm.nih.gov/mesh/D000077402 http://id.nlm.nih.gov/mesh/D011446
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4679 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9659

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128206212 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905

Total number of triples: 61.